Marker Therapeutics (MRKR) Cash from Discontinued Operations (2022 - 2023)
Marker Therapeutics (MRKR) posted quarterly Cash from Discontinued Operations of 62938.0 for Q4 2023, up 97.14% year-over-year from 31925.3 in Q4 2022, and up 75.82% quarter-over-quarter from 260281.0 in Q3 2023.
Marker Therapeutics (MRKR) Cash from Discontinued Operations (2022 - 2023) Analysis & Trends
Marker Therapeutics (MRKR) has reported Cash from Discontinued Operations for 2 consecutive years, with 62938.0 the latest figure, recorded in Q4 2023.
- In Q4 2023, Cash from Discontinued Operations rose 97.14% year-over-year to 62938.0; the TTM figure through Dec 2023 stood at 6098899.0 (changed N/A YoY), while the FY2023 annual figure was 6098899.0, down 11.73% from the prior year.
- Cash from Discontinued Operations advanced to 62938.0 in Q4 2023 per MRKR's latest filing, from 260281.0 in the prior quarter.
- Across five years, Cash from Discontinued Operations topped out at 62938.0 in Q4 2023 and bottomed at 2985556.0 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Marker Therapeutics | 27.04 Mn | 15.11 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -62,938.00 |
| Dec 31, 2023 | -62,938.00 |
| Sep 30, 2023 | -260,281.00 |
| Sep 30, 2023 | -260,281.00 |
| Jun 30, 2023 | -2.99 Mn |
| Jun 30, 2023 | -2.99 Mn |
| Mar 31, 2023 | -2.79 Mn |
| Mar 31, 2023 | -2.79 Mn |
| Dec 31, 2022 | -2.20 Mn |
| Dec 31, 2022 | -2.20 Mn |
| Sep 30, 2022 | -2.40 Mn |
| Sep 30, 2022 | -2.40 Mn |